Literature DB >> 18540686

Compliance with medication in nursing homes for older people: resident enforcement or resident empowerment?

Carmel M Hughes1.   

Abstract

Compliance with medication has been frequently cited as a problem for patients living in community settings. However, there has been little commentary on compliance issues for residents in nursing homes. This is probably due to the assumption that residents will receive their medication on a regular basis and administration will be supervised and, therefore, compliance is not perceived to be a problem. However, regular compliance may not always be appropriate if the medication has not been reviewed for appropriateness and this 'enforced' compliance may give rise to side effects or adverse effects. Residents may also be exposed to 'erratic' compliance because of inconvenient administration times for staff or difficult and time-consuming administration instructions. This may have clinical implications for residents who require medication at regular intervals, e.g. those who have Parkinson's disease. Enforced or erratic compliance is at odds with shared decision making, which is being promoted as a way of empowering patients. It could be argued that because of a high degree of cognitive impairment, it is not appropriate for nursing home residents to become involved in decision making about medications. However, the nursing home population is heterogeneous in nature and the assumption should not be made that all residents are incapable of becoming more involved in some aspects of their own care. A greater focus on resident-centred care may promote more empowerment and autonomy, both generally and with respect to compliance with medication in particular, in nursing home residents.

Entities:  

Mesh:

Year:  2008        PMID: 18540686     DOI: 10.2165/00002512-200825060-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  66 in total

1.  The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective.

Authors:  C M Hughes; K L Lapane; V Mor; N Ikegami; P V Jónsson; G Ljunggren; A Sgadari
Journal:  J Am Geriatr Soc       Date:  2000-08       Impact factor: 5.562

2.  An evaluation of the impact of the prospective payment system on antidepressant use in nursing home residents.

Authors:  Kate L Lapane; Carmel M Hughes
Journal:  Med Care       Date:  2004-01       Impact factor: 2.983

3.  Psychotherapeutic medications in the nursing home. Board of Directors of the American Association for Geriatric Psychiatry, Clinical Practice Committee of the American Geriatrics Society, and Committee on Long-Term Care and Treatment for the Elderly, American Psychiatric Association.

Authors: 
Journal:  J Am Geriatr Soc       Date:  1992-09       Impact factor: 5.562

4.  Influenza vaccination in Dutch nursing homes: is tacit consent morally justified?

Authors:  M F Verweij; M A van den Hoven
Journal:  Med Health Care Philos       Date:  2005

5.  Radical redesign of nursing homes: applying the green house concept in Tupelo, Mississippi.

Authors:  Judith Rabig; William Thomas; Rosalie A Kane; Lois J Cutler; Steve McAlilly
Journal:  Gerontologist       Date:  2006-08

Review 6.  Optimising drug treatment for elderly people: the prescribing cascade.

Authors:  P A Rochon; J H Gurwitz
Journal:  BMJ       Date:  1997-10-25

7.  A pill in the sandwich: covert medication in food and drink.

Authors:  A Treloar; B Beats; M Philpot
Journal:  J R Soc Med       Date:  2000-08       Impact factor: 5.344

8.  Optimising drug utilisation in long term care.

Authors:  Kate L Lapane; Carmel M Hughes
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

9.  Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study.

Authors:  Tom Fahey; Alan A Montgomery; James Barnes; Jo Protheroe
Journal:  BMJ       Date:  2003-03-15

10.  Prevalence of inappropriate medication using Beers criteria in Japanese long-term care facilities.

Authors:  Satoko Niwata; Yukari Yamada; Naoki Ikegami
Journal:  BMC Geriatr       Date:  2006-01-11       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.